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Abstract 
Multidrug resistant Salmonella Kentucky strains have been isolated from turkeys in 
Poland since 2009. Multiple mutations within chromosomal genes gyrA, parC and parE were 
responsible for high-level ciprofloxacin resistance. One of the isolates was extended spectrum 
β-lactamase- (ESBL) positive: the strain 1643/10 carried a conjugative 167779 bps plasmid of 
IncA/C family. The sequence analysis revealed that it carried a blaCTX-M-25 gene and an 
integron with another β-lactamase encoding gene – blaOXA-21. This is the first known report of 
a CTX-M-25 encoding gene both in Poland and in Salmonella Kentucky world-wide, as well 
as in the IncA/C plasmid. Analysis of the integron showed a novel arrangement of gene 
cassettes – aacA4, aacC-A1 and blaOXA-21 where the latter might result from an intergeneric 
gene transfer. The study confirmed Salmonella Kentucky population isolated in Poland 
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belongs to global epidemics of high level fluoroquinolone resistant clone ST198 that can carry 
rare β-lactamase genes. 
Keywords: Extended spectrum beta lactamases (ESBLs), plasmid-mediated resistance, 
quinolone resistance, IncA/C 
Introduction 
 Resistance of Salmonella to critically important antimicrobials such as cephalosporins 
and fluoroquinolones is currently one of the major public health concerns. In usually self-
limiting salmonellosis a scary scenario starts if the infection is invasive and caused by multi-
drug resistant (MDR) strain harboring transmissible resistance and virulence determinants 
(Douard et al., 2010). Salmonella enterica subsp. enterica serovar (S.) Kentucky is known for 
decades with mostly antibiotic susceptible clones appearing in poultry in the US, Ireland 
(Boyle et al., 2010; Johnson et al., 2010; Melendez et al., 2010), and recently in exotic reptiles 
in Poland (Zając et al., 2013). Currently the attention is focused on multilocus sequence type 
ST198 clone that emerged in Egypt and became MDR due to selective pressure of 
antimicrobial usage in poultry (Le Hello et al., 2011). International food production and 
supply as well as travels contributed to its rapid spread in Africa, Asia, Europe and North 
America (Beutlich et al., 2012; Bonalli et al., 2012; Le Hello et al., 2011; Mulvey et al., 2013; 
Turki et al., 2012) and is leading to global establishment of the challenging bacterial clone (Le 
Hello et al., 2013a). Salmonella control measures implemented in poultry are being hampered 
by various reservoirs of the pathogen including animals and food of animal origin, companion 
and wildlife animals, environment, and humans (Beutlich et al., 2012; Le Hello et al., 2013a; 
Zając et al., 2013) as well as long-term environmental persistence due to biofilm formation 
(Turki et al., 2012). Furthermore, recent reports have pinpointed the possibility of human-
borne clinical infection in animals (Guillon et al., 2013) and predilection of the clone to cause 
infection in turkey (Beutlich et al., 2012; Wasyl and Hoszowski, 2012).  
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 Over the last decades multiple examples of MDR Salmonella serovars got attention 
mostly due to resistance encoded by Salmonella Genomic Island (SGI1). The contribution of 
conjugal transfer of IncA/C helper plasmid pR55 for SGI1 acquisition has been recently 
shown (Douard et al., 2010). Continuous genomic rearrangements within SGI1 (Doublet et 
al., 2008) point out on the ongoing evolution of S. Kentucky ST198 epidemic clone (Beutlich 
et al., 2012; Le Hello et al., 2012; Mulvey et al., 2013; Wasyl and Hoszowski, 2012; Zając et 
al., 2013). The most notable features of a contemporary ST198 clone are MDR (amoxicillin, 
streptomycin, spectinomycin, gentamicin, sulfamethoxazole, and tetracycline) and heavy 
metals resistance related to Salmonella genomic island (SGI),high level fluoroquinolone 
resistance, and occasionally plasmid-mediated resistance to cephalosporins and carbapenems 
(Le Hello et al., 2013b; Le Hello et al., 2011; Le Hello et al., 2012; Turki et al., 2012). 
Typically for Salmonella, quinolone resistance results from spontaneous, consecutive 
mutations of chromosomal topoisomerases genes (gyrA, gyrB, parC, parE) and step-wise 
amino-acid substitutions are needed for high-level resistance. Resistance phenotype might be 
further modulated with multiple plasmid-mediated quinolone resistance mechanisms (PMQR) 
(Gunell et al., 2009; Le Hello et al., 2011; Luo et al., 2011; Wasyl et al., 2014). 
The genes conferring antibiotic resistance located on plasmids with replicons 
belonging to IncI1, IncN, IncFIB, IncFIIA, IncW, IncA/C and IncL/M incompatibility groups 
were detected in S. Kentucky. Plasmids carried PMQR, -lactam, cephalosporin, carbapenem, 
tetracycline, and azithromycin resistance genes (Garcia-Fernandez et al., 2009; Harrois et al., 
2013; Le Hello et al., 2013b; Melendez et al., 2010). Moreover, ColV plasmids with 
IncFIB/FIIA replicons, encoding several virulence factors were responsible for enhanced 
colonization and virulence in poultry and S. Kentucky persistence in farm environment 
(Johnson et al., 2010). Mentioned above IncA/C plasmids constitute another large plasmid 
family found in S. Kentucky and broad range of hosts. The prototypic pRA1 plasmid was 
Komentarz [i1]: dodałam 
Komentarz [i2]: Nie ma wspomnienych 
wczesniej. 
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isolated in 1971 in Japan from tetracycline and sulfonamide resistant Aeromonas hydrophila 
and up-to date members of the family have been isolated worldwide from different human and 
animal pathogens (see del Castillo et al., 2013 and citations therein). The plasmid conserved 
backbone (74-100% sequence identity of IncA/C family members) comprises of a replication 
region, a stability module and a transfer moiety which displays sequence identity to 
integrative conjugative element (ICE) SXT/R391 (Johnson and Lang, 2012). The integration 
of various transposons (Tn) or insertion sequences (IS) introducing different resistance gene 
arrays into hotspots in plasmid sequences resulted in the particular diversity of IncC/A family 
(Johnson and Lang, 2012). In S. Kentucky IncA/C plasmids have been found carriers of few 
cephalosporin resistance genes (Le Hello et al., 2013a; Le Hello et al., 2013b) but up to our 
knowledge none of them coded for extended-spectrum β-lactamase (ESBL). 
MDR S. Kentucky has emerged in Poland in turkey flocks and turkey meat in 2009 
(Wasyl and Hoszowski, 2012). Further studies confirmed ST198 being responsible for the 
epidemics (Le Hello et al., 2013a; Zając et al., 2013). Current follow-up study aimed at 
identification of mechanisms responsible for high-level fluoroquinolone and cephalosporin 
resistance including detail characterization of plasmid carrying ESBL determinants. 
Materials and Methods 
 Bacterial strains 
Twenty-seven S. Kentucky isolates of previously described epidemiological relations 
representing the ST198 clone (Wasyl and Hoszowski, 2012; Zając et al., 2013) were further 
investigated. They were isolated between July 2009 and December 2010 from turkeys 
(N=15), turkey or unspecified poultry meat (N=5), food production hygiene checks (N=4), 
feed (N=2) and municipal sewage sludge (N=1). The following laboratory Escherichia coli 
recipient strains were used: for transformation TOP10 (F
-
 mcrA Δ(mrr-hsdRMS-mcrBC), 
φ80lacZΔM15 ΔlacX74 nupG recA1 araD139 Δ(ara-leu)7697 galE15 galK16 rpsL(StrR) 
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endA1 λ-) (Invitrogen, Life Technologies, CA, USA), in matings JE2571RifR (leu thr thi lacY 
thy pil fla rif
R
) (Gołębiewski et al., 2007). 
 Antimicrobial resistance testing 
Minimal inhibitory concentrations (MICs) of quinolones (nalidixic acid – Nal and 
ciprofloxacin – CIP) and cephalosporins (cefotaxime – CTX and ceftazidime – CAZ) were 
determined with microbroth dilution method (Sensititre®, Trek Diagnostic Systems, UK) and 
interpreted according to epidemiological cut-off values as described previously (Wasyl and 
Hoszowski, 2012). 
 Identification of resistance determinants 
Quinolone Resistance Determining Regions (QRDR) of the genes encoding for gyrase 
subunits A and B (gyrA, gyrB) and topoisomerase IV subunits C and E (parC, parE) and 
Plasmid Mediated Quinolone Resistance (PMQR) genes (qnrA, qnrB, qnrC, qnrD, qnrS, 
qepA, aac(6’)-Ib-cr) were tested as described previously (Wasyl et al., 2014). Relevant 
QRDR amplicons were sequenced (Genetic Analyser 3500, Life Technologies). The 
nucleotide sequences were analyzed with SeqMan Pro (DNA Star Lasergene) and MEGA5 
software (Center for Evolutionary Medicine and Informatics), compared against reference 
sequences and deposited in GenBank under Accession Numbers: KC172109 ÷ KC172135 
(gyrA), KC172136 ÷ KC172162 (parC), and KC172163 ÷ KC172189 (parE). Identification 
of cephalosporin resistance determinant (PCR targeting blaCTX-M) has been done as described 
previously (Wasyl and Hoszowski, 2012) with final identification of the gene during plasmid 
sequence analysis.  
Plasmid analyses 
Previously described (Hoszowski et al., 1999) alkaline lysis method was used for 
plasmid profile screening with E. coli 39R and V517 as reference markers. Detailed plasmid 
characterization of four selected isolates was done with endonuclease S1-PFGE (Pulsed-field 
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gel electrophoresis; 1% SeaKem GTG agarose -FMC Bioproducts, USA; 6V/cm, switch time 
1-25 s, 120, 14C, 20 h) (Barton et al., 1995) and PCR-based replicon typing (PBRT) using 
genomic DNAs (Carattoli et al., 2005). Electroporation was performed with One Shot® 
TOP10 Electrocomp™ E. coli according to manufacturer’s protocol (Invitrogen, USA).  
Plasmid conjugal transfer 
One millilitre volumes containing 10
9
 CFU of donor and recipient strain LB cultures 
(Luria-Bertani broth; Biocorp, Poland) were mixed and incubated for 30 min at 37°C. 
Conjugation was stopped by vigorous vortexing for 30 s and placing the mating mixture on 
ice. Transconjugants
 
were selected on LB agar (Biocorp) supplemented with cefotaxime
 
(2 
mg/L; Polfa Tarchomin, Poland) and rifampin (100 mg/L; Polfa Tarchomin). Solid mating 
was performed likewise, with an additional step of filtering the mating mixture through the 
sterile Millipore HA 45 µm filter (Millipore, USA) followed by incubation on LB plate. In the 
control experiments, the frequency of spontaneous mutations of both the donor and the 
recipient to the phenotype of transconjugants was assessed. 
Plasmid DNA analysis 
Transconjugant plasmid DNA was purified using the Plasmid Midi AX DNA kit 20 
(A&A Biotechnology, Poland) and bacterial genomic DNA was purified using Genomic Mini 
kit (A&A Biotechnology). Pyrosequencing was performed on Genome Sequencer GS FLX+ 
Titanium (454) and the sequence was initially assembled using Newbler de Novo Assembler 
ver. 2.8 (454 Life Sciences, a Roche Company, USA). The gaps were filled after sequencing 
of PCR products generated from primers designed to the contig ends and finally the plasmid 
circle was closed and verified by restriction analysis performed in vitro and in silico. Plasmid 
sequence was analyzed using Clone Manager 9 Professional Edition ver. 9.2 and National 
Center of Biotechnology Basic Local Alignment Search Tool (BLAST). The whole p1643_10 
sequence was compared and aligned to IncA/C plasmids using the Artemis Comparison Tool 
Komentarz [i3]: Wyrzyciłam nawias, 
żeby nie było podwójnego 
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(http://sanger.ac.uk) and mosaic resistance region was analyzed with ISFinder (https://www-
is.biotoul.fr/) (Siguier et al., 2006). The complete nucleotide sequence of p1643_10 has been 
submitted to the GenBank database under Acc. No. KF056330.  
Results 
MICs 
High level fluoroquinolone resistance was observed in 25 isolates (MICNal > 64 mg/L 
and MICCip ≥8 mg/L). Isolate 1643/2010 and its transformants showed resistance to 
cefotaxime (MICCTX > 4 mg/L) and ceftazidime (MICCAZ > 16 mg/L), while the remaining 
isolates were susceptible to CTX and CAZ.. 
Quinolone and cephalosporin resistance determinants 
Sequencing of expected molecular weight amplicons of topoisomerases genes revealed 
substitutions in subunit GyrA (Ser83→Phe, Asp87→Tyr), ParC (Tyr57 →Ser, Ser80 →Ile) 
while no quinolone relevant mutations were found in gyrB and parE genes. The isolates were 
found negative for all tested PMQR determinants (data not shown). Isolate 1643/2010 and its 
transformants showed blaCTX-M specific amplicon further identified via plasmid sequencing as 
blaCTX-M-25. 
Plasmid analysis 
Numerous profiles comprising up to several plasmids of various molecular weight 
were noted in most of tested isolates (data not shown). High molecular weight plasmids were 
noted only in four isolates. S1-PFGE identified ca. 70-80 kb plasmids in three of them 
(1424/2010, 1719/2010, and 2238/2010), CTX-M producing isolate 1643/2010 carried 
plasmid of approximately 150 kb in size. The PBRT performed on genomic DNA classified 
plasmids of the three mentioned isolates to IncI1 group while the one observed in 1643/2010 
– to IncA/C group. The plasmid of strain 1643/2010, p1643_10, was transferred by 
electroporation to laboratory TOP10 E. coli strain. Then, it was conjugally transferred from 
Komentarz [i4]: dodałam 
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the TOP10p1643_10 cells to JE2571Rif
R
 strain with the efficiency of 10
-3
 ÷ 10-4 per donor cell. 
Sequencing of the p1643_10 plasmid revealed that it was 167779 bps in size (FIG. 1), coded 
for 168 ORFs of which all had homologs in public databases. The plasmid shared extended 
homology of its backbone (replication-, stability-, conjugative transfer-encoding regions) with 
other sequenced IncA/C plasmids such as pR55, pTC2, pP91278 and others (FIG. 2). The 
majority of p1643_10 sequence (pos. 1 to 106549 and 147283 to 167779) displayed syntheny 
(with at least 99% identity) with a large fragment of pTC2 (pos. 156977 to 29205). The 
remaining part of the sequence (pos.106550-147282) constitute a single mosaic MDR region 
of interesting structure (FIG. 3). All but two phage-related, of nineteen full or truncated 
transposase or integrase genes present in p1643_10 sequence had been found there. Moreover, 
this region comprises eleven genes involved in resistance to antimicrobials: aphA1, strA, strB, 
sul2, aadB, an integron with the novel array of gene cassettes: aacA4, aacC-A1, blaOXA-21 and 
qacEΔ1 and sul1 in its 3’-CS, as well as the blaCTX-M-25 gene and the mercure resistance 
operon, merEDACPTR. A composite transposon with aphA1 gene flanked by IS26 sequences 
(pos. 110625 to 113201) is also in 99% identical to part of pTC2, however, it is separated 
from the mentioned pTC2 fragment by the IS4321R integration site (pos. 106459 to 107789) 
downstream the rhsA gene. Such a genetic structure with the composite transposon situated 
next to the region comprising strA, strB, sul2 genes and a truncated IncQ replicon, is identical 
to the region found in S. Typhimurium F-like plasmid pU302L (Chen et al., 2007). The other 
part of the p1643_10 sequence, from tniA gene, comprising the mer operon, to the plasmid 
end (pos. 134525 to 167779) shares 99% identity with pTC2 except of the site of ISEcp1 
integration. This transposition brought blaCTX-M-25 gene, however, the ISEcp1 transposase 
gene was subsequently disrupted by IS50A insertion. Such blaCTX-M-25 genetic environment 
had been found in ca. 111 kb plasmid pCTX25 in Canada (Munday et al., 2004) (FIG. 3). The 
middle part of the mosaic MDR region is a hot spot of recombination and comprise the ISs 
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(ISc35, IS5D, ISEhe3 with orfB truncated), together with a second, single copy of the 
integron intI1 gene, a putative resolvase gene and a region containing the short remnants 
group II intron and ISCR20. Only IS5D was found to have the complete terminal inverted 
repeats (IR) indicating probably the newest integration event. Interestingly, the large plasmid 
region outside the mosaic MDR region (from pos. ca. 107000 to 146000) was noticed to 
contain significantly less restriction enzymes recognition sites (for restrictases recognizing up 
to 10 sites) than the rest of the plasmid and overlapped with the plasmid backbone. 
Discussion 
 Within the current study, resistance mechanisms to antimicrobials critical for public 
health: fluoroquinolones and cephalosporins have been identified in a selection of S. 
Kentucky isolated in Poland. Until the described S. Kentucky epidemics (Wasyl and 
Hoszowski, 2012) none of Salmonella isolates monitored for antimicrobial resistance was 
ESBL positive. Clinical fluoroquinolone resistance (MIC > 1 mg/L) was observed in 0.8% of 
2680 tested isolates. High-level MIC (MIC ≥8 mg/L) was noted only in S. Newport and 
S. Enteritidis (two isolates each) but mostly in S. Kentucky (Wasyl et al., 2014). Those 
isolates belonged to ST198 clone spreading in animals, foods, and humans in numerous 
countries(Beutlich et al., 2012; Bonalli et al., 2012; Le Hello et al., 2013a; Zając et al., 2013), 
while the susceptible ones represented reptile-related sequence type ST314 occurring in 
Poland(Zając et al., 2013). SGI1 variants harboring resistance gene clusters have been found 
responsible for diverse MDR phenotypes observed in S. Kentucky (Beutlich et al., 2012; 
Doublet et al., 2008; Le Hello et al., 2012). The presence of integrative and mobilizable SGI1 
along with currently described chromosomal and transferable elements is of major scientific 
and epidemiological concerns (Le Hello et al., 2013a). 
The genetic background of fluoroquinolone resistance confirmed that it is a step-wise 
phenomenon, affecting both gyrA and parC genes as targets to reach high-level ciprofloxacin 
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resistance (Le Hello et al., 2011). Most of the studied isolates revealed already described 
substitutions (Gunell et al., 2009; Luo et al., 2011; Wasyl et al., 2014) but the combination of 
Ser83→Phe and Asp87→Tyr in GyrA subunit and Ser80→Ile in ParC is extremely rare and, 
up to our knowledge, limited to epidemic population of S. Kentucky ST198 (Beutlich et al., 
2012; Le Hello et al., 2013a; Le Hello et al., 2011). . Although S. Kentucky was reported to 
carry qnrD (Cavaco et al., 2009) and qnrS1 (Garcia-Fernandez et al., 2009) none of the tested 
PMQR mechanisms was observed in the studied population. Our previous report of ST198 
occurrence (Zając et al., 2013) along with currently described multiple mutation pattern 
clearly confirmed Poland as a part of word-wide epidemics of MDR S. Kentucky. 
Several cephalosporin resistance mechanisms, including extended-spectrum β-
lactamases (SHV-12, CTX-M-1, CTX-M-15), cephalosporinases (CMY-2), and 
carbapenemases (OXA-48, VIM-2) (Boyle et al., 2010; Harrois et al., 2013; Le Hello et al., 
2013b) have been described in S. Kentucky. Up to our knowledge this is not only the first 
study describing blaCTX-M-25 in S. Kentucky, but also the first report of this gene in IncA/C 
plasmid and its first appearance in Poland. CTX-M-25 have been firstly described in 2000 in 
Escherichia coli from Canadian patient (Munday et al., 2004). It is currently considered a 
representative for the subgroup of few β-lactamases rarely occurring worldwide (Vervoort et 
al., 2012). The unique genes of blaCTX-M family that have been found so far in Poland code for 
CTX-M-3 and CTX-M-15 (Empel et al., 2008; Gołębiewski et al., 2007) in human clinical 
cases and CTX-M-1 in non-diseased animals (Wasyl et al., 2012). The blaCTX-M-25 carrying 
plasmid, p1643_10, was identified as member of a large IncA/C family (FIG. 2) composed of 
predominantly conjugative, broad-host range plasmids (Fricke et al., 2009; Johnson and Lang, 
2012; Lindsey et al., 2009). The highly conserved backbone of these plasmids contains 
integration hot spots where different MDR regions are introduced to the sequence. In the 
p1643_10 sequence a single mosaic MDR region spanning ca. 40 kb have been identified, 
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integrated next to the complete rhsA gene (FIG. 3). The molecular history of this region is 
difficult to establish, however, the presence of complete terminal IRs of IS5D suggests the 
most recent transposition events. Also IS4321R presumably recently come into p1643_10 as 
its integration site distinguishes p1643_10 from pTC2 and pKEC-a3c plasmids. The blaCTX-M-
25 way into p1643_10 after being mobilized by ISEcp1 is hard to retrace since the pCTX25 
sequence available in public databases is short. The class 1 integron detected in p1643_10 
sequence contains a novel cassettes array. Plasmid pKEC-a3c from Citrobacter freundii 
recently published in GenBank contains an integron similar to that of p1643_10 however it 
lacks blaOXA-21 cassette. In p1643_10 integron containing two of gene cassettes, namely, 
aacA4, aacC-A1, together with aadB and aphA1 genes confers resistance to entire spectrum of 
clinically used aminoglycosides. The other gene cassette, blaOXA-21, is identical to the variant 
found in integrons of Acinetobacter and Klebsiella (Doublet et al., 2012; Yamamoto et al., 
2011) and might be a result of a transgeneric gene transfer. 
 Epidemiological investigation in farm where the CTX-M-25 and OXA-21 producing 
isolate originated from did not show any other β-lactam resistant Salmonella, although multi-
drug resistant S. Kentucky was isolated either from the same and the following turkey flocks 
(Wasyl and Hoszowski, 2012).The plasmid carrying cephalosporin resistance genes must 
have been acquired from environmental source during turkey infection. This hypothesis might 
be supported by high IncA/C plasmids transferability in S. Kentucky (Fricke et al., 2009). The 
resistance probably did not offer any survival advantage to the recipient strain and it 
disappeared soon after. Such scenario cannot be excluded, although we failed to find any 
CTX-M positive commensal Escherichia coli in environmental samples taken few months 
after the incident of blaCTX-M-25 carrying S. Kentucky.  
Finding of rare β-lactamase genes draw the attention to plasmids that can be easily 
acquired by Salmonella followed by further epidemic spread as described in OXA-48 and 
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VIM-1 producing S. Kentucky ST198 (Le Hello et al., 2013b). They also seem to be an 
important factor influencing genetic adaptation of S. Kentucky, both to increase its virulence 
(Johnson et al., 2010) and resistance to quinolones (Garcia-Fernandez et al., 2009) and 
cephalosporins (Bonalli et al., 2012). Multiple plasmids of broad–range molecular weight 
were also observed in our study (data not shown), but here we have focused on a single isolate 
carrying IncA/C plasmid. Considering genetic plasticity of S. Kentucky ST198, our result 
show that it might further alter its genome by acquisition of genetically diverse plasmids. 
 Based on current results as well as our previous and reviewed studies we claim that S. 
Kentucky population isolated in Poland belongs to world-wide epidemics of multidrug 
resistant and high level fluoroquinolone resistant S. Kentucky. Finding of rare cephalosporin 
resistance genes on a transferable plasmid multiplies possible consequences of human 
infection with a pathogen resistant to all antimicrobial classes used to treat systemic 
salmonellosis. Build on multiple studies showing genetic plasticity of S. Kentucky clone, 
current result indicate that the epidemic strain might further modify its gene content by 
acquisition of genetically diverse plasmids. Therefore S. Kentucky remains intriguing 
challenge for future epidemiological studies and research. 
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Figure captions 1 
Fig. 1 Structure of the p1643_10 plasmid. Circular map of the p1643_10 plasmid. Genes are colour-2 
coded depending on functional annotations: plasmid replication (blue boxes), plasmid maintenance 3 
(pink), DNA methylation (light pink), conjugative plasmid transfer (green), 4 
transposition/recombination (yellow), resistance (red), others (light blue). The two external box-5 
circles depicture coding strands; the third circle – peseudogenes. The inner black circle indicate 6 
regions identical (min. 99%) with pTC2, another IncA/C plasmid (GenBank Acc. No. JQ824049). 7 
The figure appears in colour in the online version of paper and in black and white in its print 8 
version. 9 
Fig. 2 Structure of the p1643_10 plasmid. Sequence comparisons of p1643_10 with IncA/C 10 
plasmids: pTC2 (Providentia stuartii, Greece, 2008), pR55 (Klebsiella pneumniae, France, 1969, 11 
GenBank Acc. No. JQ010984), pP91278 (Photobacterium damselae subsp. piscicida, USA, 1991, 12 
GenBank Acc. No. AB277724) and pKEC-a3c (Citrobacter freundii CFNIH1, USA, 2014, 13 
GenBank Acc. No. CP007558). Comparisons were performed using the Artemis Comparison Tool 14 
with a minimum score cut-off of 800 and a minimum percentage identity cut-off of 99%. Forward 15 
and reverse matches are coloured in red and blue, respectively. The figure appears in colour in the 16 
online version of paper and in black and white in its print version. 17 
Fig 3. Sequence analysis of the mosaic resistance region of p1643_10. Arrows indicate ORFs 18 
identified by sequence analysis: black filling – resistance genes, grey transposition associated, white 19 
– of other function; truncated genes are marked as broken arrows. Tiny grey boxes indicate IS 20 
terminal inverted repeats identified using ISFinder. Grey boxes beneath indicate parts of plasmids: 21 
pU302L (Acc. No. AY333434.1), pCTX25 (partial sequence available - Acc. No. AF518567), 22 
pKEC-a3c (Acc. No. CP007558), pTC2, with structures similar to p1643_10. All regions are drawn 23 
to scale. 24 
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